Bayomac India Private Limited
About Bayomac India Private Limited
Data last updated:
Bayomac India Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 September 1996.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24237DL1996PTC082142.
The company had an authorised share capital of ₹1 Cr and a paid-up capital of ₹56.66 Lakh. It was formerly known as Bayomac India Limited. It was led by directors including Madhur Singhal and Pratima Singhal.
Its last annual general meeting (AGM) was held on 28 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Unit No – 5 Ground Floor, Uppal Plaza M6 Plot No – 6 Jasola, New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2023, the company reported a revenue of ₹13.43 Lakh, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹4.11 Lakh (net margin 30.6%) and EBITDA of ₹5.51 Lakh (EBITDA margin 41.1%). Revenue has grown at a compounded annual rate (CAGR) of 51% over three years and 6% over five years.
Court records list 5 cases involving the company, including 5 filed by the company.
Company details
Contact details
Bayomac India Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressUnit No – 5 Ground Floor, Uppal Plaza M6 Plot No – 6 Jasola, New Delhi, Delhi, India – 110025
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bayomac India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Bayomac India Private Limited
FY 2023 filings availableBayomac India Private Limited reported revenue of ₹13.43 Lakh (up 38% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 38% growth in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.11 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 41.1% | ||||
| Net Profit Margin | 30.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bayomac India Private Limited, buy the company report.
Board of directors of Bayomac India Private Limited
Bayomac India has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhur Singhal | Director | 01 Sep 2014 | 12 Years 1 Months | As last reported |
| Pratima Singhal | Director | 30 May 2012 | 14 Years 4 Months | As last reported |
| Praneet Singhal | Director | 01 Sep 2014 | 12 Years 1 Months | As last reported |
| Pradeep Kumar Singhal | Director | 30 May 2012 | 14 Years 4 Months | As last reported |
Peer comparison
Bayomac India Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Syngen Laboratories Private Limited | ₹13.63 Lakh (FY 2025) | 4.0% | Hyderabad, Telangana, India | |||
| Sangie Pharmaceuticals Private Limited | ₹13.57 Lakh (FY 2025) | -80.0% | Thane, Maharashtra, India | |||
| Pharma Base India Private Limited | ₹13.51 Lakh (FY 2025) | -99.0% | Mumbai, Maharashtra, India | |||
| Plazma Laboratories Pvt Ltd | ₹13.49 Lakh (FY 2025) | Indore, Madhya Pradesh, India | ||||
| Amishi Naturals Private Limited | ₹13.47 Lakh (FY 2018) | Karnal, Haryana, India | ||||
| Bayomac India Private Limitedthis company | ₹13.43 Lakh (FY 2023) | ₹4.11 Lakh | 30.6% | 38.0% | New Delhi, Delhi, India | |
| Gerameds Healthcare (OPC) Private Limited | ₹13.32 Lakh (FY 2023) | -40.0% | Ghaziabad, Uttar Pradesh, India | |||
| Brunex Pharmaceuticals Private Limited | ₹13.32 Lakh (FY 2022) | -63.0% | Bangalore, Karnataka, India | |||
| Aveerax Biotech Private Limited | ₹13.29 Lakh (FY 2025) | 72.0% | Delhi, India | |||
| Adriean Healthcare Private Limited | ₹13.25 Lakh (FY 2024) | Aurangabad, Maharashtra, India | ||||
| Radhim Biotech Private Limited | ₹13.22 Lakh (FY 2025) | -84.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Bayomac India Private Limited, buy the company report.
Auditor
Bayomac India Private Limited is audited by PAWAN NANAK BANSAL & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PAWAN NANAK BANSAL & CO | FY 2020 | 008953C |
Shareholding
The shareholding of Bayomac India Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Bayomac India Private Limited, buy the company report.
Legal cases
Bayomac India Private Limited has 5 court cases on record: 5 filed by Bayomac India. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 0 | 0 |
Cases on record (2 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gautam Buddha Nagar, Uttar Pradesh | Court case (Complaint Cases) | Filed by the company against Ms. Cyrus Developers Pvt. Ltd. | Disposed |
| District court, North, Delhi | Criminal case | Filed by the company against Cyrus Developement Pvt Ltd Anr. | Disposed |
To see the full case history of Bayomac India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bayomac India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bayomac India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bayomac India Private Limited has 6 board changes on record since 2012: 4 appointments and 2 cessations. The latest: Madhur Singhal was appointed as Director on 01 Sep 2014.
Frequently asked questions
Bayomac India has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Bayomac India was a private limited company based in New Delhi, Delhi, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 23 September 1996 and is registered under CIN U24237DL1996PTC082142. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Bayomac India is U24237DL1996PTC082142. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bayomac India had 4 directors:
- Madhur Singhal - Director
- Pratima Singhal - Director
- Praneet Singhal - Director
- Pradeep Kumar Singhal - Director
Bayomac India was incorporated on 23 September 1996. It is registered with the Registrar of Companies, Delhi.
The registered office of Bayomac India is at Unit No – 5 Ground Floor, Uppal Plaza M6 Plot No – 6 Jasola, New Delhi, Delhi, India – 110025.
The latest financial statements of Bayomac India on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 28 September 2023. Year-wise statements from 2015 are in the company report.
Bayomac India operated in the pharma industry, in the drug formulation and development segment.
The peers of Bayomac India by revenue are Syngen Laboratories Private Limited, Sangie Pharmaceuticals Private Limited, Pharma Base India Private Limited, Plazma Laboratories Pvt Ltd, Amishi Naturals Private Limited and 5 more, all in the Pharma industry (Formulations).
Bayomac India has 5 court cases on record: 5 filed by the company.
Madhur Singhal was appointed as Director on 01 Sep 2014. Praneet Singhal was appointed as Director on 01 Sep 2014. Pawan Kumar Bansal ceased to be Director on 12 Jun 2012. Bayomac India has 6 board changes on record in total.